LGR6 promotes CRC cell proliferation and migration in vitro by activating the PI3K/AKT signaling pathway and was suggested to serve as a predictive biomarker of CRC primary tumors for bad prognosis and a therapeutic target for patients with advanced stages of CRC (20). This evidence concerns the gene LGR6 and colorectal carcinoma.